NASDAQ
Akebia Therapeutics, Inc. (AKBA) has a interest coverage ratio of 0.97x as of Friday, May 29, 2026. This represents a 113.47% increase compared to its 12-month average of -7.22x. The interest coverage ratio measures how easily a company can pay interest on its outstanding debt from operating earnings.
No price data available for this timeframe.